JDS Therapeutics sells Nutrition21 to Everwell
JDS Therapeutics has sold its specialty ingredient subsidiary, Nutrition21, to Everwell Health Holdings, which is backed by RoundTable Healthcare Partners.
11 November 2021•3 mins read
JDS Therapeutics has sold its specialty ingredient subsidiary, Nutrition21, to Everwell Health Holdings, which is backed by RoundTable Healthcare Partners.
Pollen Street-backed Leonard Curtis adds Norwich insolvency firm Parker Andrews
33 minutes ago · 2 mins read
PAI Partners agrees to acquire Elemis from L’Occitane Group
3 hours ago · 2 mins read
BGF takes minority stake in reptile products supplier Monkfield Reptile
3 hours ago · 2 mins read
LDC-backed Stonbury adds engineering firm MTS in second deal in two weeks
4 hours ago · 2 mins read
Beech Tree-backed Inspiro Learning adds Safety UK Group as third add-on
4 hours ago · 2 mins read
Capmont takes majority stake in Kramer Group in succession deal
4 hours ago · 2 mins read
Cordatus Capital makes majority investment in floor abrasives maker Diamabrush
4 hours ago · 1 min read
